The Measure of a Great Industry is Who's Listening

In June 2003, the Biotechnology Industry Organization (BIO) brought its annual convention to Washington, D.C., setting the stage for an unprecedented exchange of views and expectations between biotechnology leaders and our nation’s top public officials. The opportunities created by this higher political profile will serve BIO members well on the issues that matter most, such as Medicare reimbursement, FDA procedures, intellectual property protection and agricultural biotechnology regulation.